A new model has projected a substantial rise in the burden of metabolic dysfunction-associated steatotic liver disease in the ...

Addition of the anti-TIGIT monoclonal antibody tiragolumab to standard first-line treatment resulted in better response rates and improved survival for patients with unresectable hepatocellular ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.

Furthermore, patients who recovered from MAFLD showed a higher incidence rate of hepatocellular carcinoma than those without the disease. This suggests that additional information can be provided ...

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...

A sensation of fullness beneath the ribs on the right side A similar feeling under the ribs on the left side Yellowing of the ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...